PUBLICATIONS

Patil SM, Barji DS, Aziz S, McChesney DA, Bagde S, Muttil P, Kunda NK, Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment. International Journal of Pharmaceutics.  2023. doi: 10.1016/j.ijpharm.2023.122641

Patil SM*, Barji DS*, Chavan T, Patel K, Collazo AJ, Prithipaul V, Muth A, Kunda NK, Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment. AAPS PharmSciTech 24, 49 (2023). doi: 10.1208/s12249-023-02510-1

Patil SM, Kunda NK. Nisin ZP, an antimicrobial peptide, induces apoptotic cell death and inhibits non-small cell lung cancer (NSCLC) progression in vitro in 2D and 3D cell culture. Pharmaceutical Research (2022); Mar 4. doi: 10.1007/s11095-022-03220-2.

Patil SM, Kunda NK. Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC). Biochimie (2022); 201, 7-17.

Sawant SS, Patil SM, Shukla SK, Kulkarni NS, Gupta V, Kunda NK. Pulmonary Delivery of Osimertinib Liposomes for Non–Small Cell Lung Cancer treatment: Formulation Development and In-vitro Evaluation. Drug Delivery and Translational Research (2021); Nov 23. doi: 10.1007/s13346-021-01088-0.

Patil SM, Sawant SS, Kunda NK. Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC). International Journal of Pharmaceutics (2021); 121046.

Parvathaneni V, Elbatanony RS, Goyal MS, Chavan T, Vega N, Kolluru S, Muth A, Gupta V#, Kunda NK#. Repurposing Bedaquiline for Effective Non-small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-based Molecular Inclusion Complexes. International Journal of Molecular Sciences (2021); 22(9), 4783.

Yadav R, Zhai L, Kunda NK, Muttil P, Tumban E. Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51. Viruses (2021); 13(6): 1113.

Pektar K#, Patil SM, Chavhan S, Kaneko K, Sawant K, Kunda NK#, Saleem IY#. An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics (2021); 13(4), 455.

Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK#, Patel K#. Aerosolized Nanoliposomal Carrier of Remdesivir (AL-Rem)- an effective alternative for Covid-19 treatment. Nanomedicine (2021); 16(14):1187-1202.

Garza KB, Abebe E, Bacci JL, Kunda NK, Lor KB, Rickles N, Shankar N, Farrell D. Building Implementation Science Capacity in Academic Pharmacy: Report of the 2020-2021 AACP Research and Graduate Affairs Committee. American Journal of Pharmacy Education (2021); Jul 22:8718.

Alfagih IM, Kaneko K, Kunda NK, Alanazi F, Dennison SR, Tawfeek HM, Saleem IY. In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers. Pharmaceuticals (2021); 14(2):164.

Shukla SK, Sarode A, Kanabar DD, Muth A, Kunda NK, Mitragotri S, Gupta V. Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs. Materials Science and Engineering: C. (2021); 128:112324.

Parvathaneni V, Kulkarni NS, Muth A, Kunda NK, Gupta V. Therapeutic potential of inhalable medications to combat coronavirus disease-2019. Therapeutic Delivery (2021); 12(2), 105-110.

Elbatanony R, Parvathaneni V, Kulkarni NS, Chauhan G, Shukla SK, Kunda NK, Gupta V. Afatinib-loaded Inhalable PLGA Nanoparticles for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC) – Development and In-vitro Efficacy. Drug Delivery and Translational Research (2021); 11, 927–943.

Parvathaneni V, Kulkarni NS, Chauhan G, Shukla SK, Elbatanony R, Patel B, Kunda NK, Muth A, Gupta V. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy–Repurposing amodiaquine for non-small cell lung cancer (NSCLC). Materials Science and Engineering: C (2020); 115: 111139.

Sawant SS, Patil SM, Gupta V, Kunda NK. Microbes as Medicines: Harnessing the power of bacteria in advancing cancer treatment. International Journal of Molecular Sciences (2020); 21(20), 7575.

Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V. Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics (2020);12(3). pii: E206

Tawfeek HM, Chavan T, Kunda NK. Effect of Spray Drying on Amorphization of Indomethacin Nicotinamide Cocrystals; Optimization, Characterization and Stability Study. AAPS PharmSciTech (2020); 21 (5), 1-13.

Shukla SK, Kulkarni NS, Farrales P, Kanabar DD, Parvathaneni V, Kunda NK, Muth A, Gupta V. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer. Pharmaceutical Research (2020); 37(3): 1-19.

Patil SM, Sawant SS, Kunda NK. Exosomes as drug delivery systems: A brief overview and progress update. European Journal of Pharmaceutics and Biopharmaceutics (2020); 154: 259-269.

Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, Gupta V. Inhalable Resveratrol-Cyclodextrin Complex Loaded Biodegradable Nanoparticles for Enhanced Efficacy against Non-Small Cell Lung Cancer. International Journal of Biological Macromolecules (2020); 164: 638-650.

Rai G, Urban D, Mott B, Hu X, Yang, SM, Benavides G, Johnson M, Squadrito G, Brimacombe K, Lee T, Cheff D, Zhu H, Henderson MJ, Pohida K, Sulikowski G, Dranow D, Kabir M, Shah P, Padilha E, Tao D, Fang Y, Christov P, Kim K, Jana S, Muttil P, Anderson T, Kunda NK, Hathaway H, Kusewitt D, Oshima N, Cherukuri M, Davies D, Norenberg J, Sklar L, Moore W, Dang C, Stott G, Neckers L, Flint A, Usmar VD, Simeonov A, Waterson A, Jadhav A, Hall M, Maloney D. Pyrazole-Based Lactate Dehydrogenase (LDH) Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties. Journal of Medicinal Chemistry (2020); 63, 19, 10984–11011.

Kunda NK. Antimicrobial peptides as novel therapeutics for non-small cell lung cancer. Drug Discovery Today (2020); 25(1):238 – 247.

Price DN, Kunda NK, Ellis R, Muttil P. Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine. Pharmaceutical Research (2020); 37:11.

Chavan T, Muttil P, Kunda NK. “Introduction to Nanomedicine” in Mucosal Delivery of Drugs and Biologics in Nanoparticles” edited by Pavan Muttil and Nitesh K. Kunda in AAPS Advances in the Pharmaceutical Sciences Series edited by Yvonne Perrie. Springer Publisher In publication (2020).

Vaidya B, Kulkarni NS, Shukla SK, Parvathaneni V, Chauhan G, Damon JK, Sarode A, Garcia JV, Kunda NK, Mitragotri S, Gupta G. Development of Inhalable Quinacrine Loaded Bovine Serum Albumin Modified Cationic Nanoparticles: Repurposing Quinacrine for Lung Cancer Therapeutics. International Journal of Pharmaceutics (2020); 118995.

Lee J, Kunda NK. Health Literacy in Students in Queens, NY. Journal of Vincentian Social Action (2020); 5(1): 1-6.

Kunda NK#, Peabody J, Zhai L, Price DN, Chackerian B, Tumban E, Muttil P#. Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9. Human Vaccines & Immunotherapeutics (2019); 15 (7-8): 1995-2002.

Zhai L, Yadav R, Kunda NK, Anderson D, Bruckner E, Miller EK, Basu R, Muttil P, Ebenezer T. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer. Antiviral Research (2019); 166: 56-65.

Price DP*, Kunda NK*, Miller EK, Muttil P. “Inhaled Therapeutics against TB: the Promise of Pulmonary Treatment and Prevention Strategies in the Clinic.” for Inhalation Aerosols Physical and Biological Basis for Therapy edited by Anthony J. Hickey and Heidi M. Mansour in series Lung Biology in Health and Disease edited by Dr. Claude Lenfant. Informa Healthcare/CRC Press/Taylor & Francis (2019); 1: 361-375.

Mohammed A, Kunda NK, Ross K, Hutcheon G, Saleem IY. Polymeric Nanoparticles for the Delivery of miRNA to Treat Chronic Obstructive Pulmonary Disease (COPD). European Journal of Pharmaceutics and Biopharmaceutics (2019); 136:1-8.

Zychowski KE, Wheeler A, Sanchez B, Harmon M, Steadman-Tyler CR, Herbert G, Lucas SN, Ali AM, Avasarala S, Kunda NK, Robinson P, Muttil P, Cerrato JM, Bleske B, Smirnova O, Campen MJ. Toxic effects of particulate matter derived from dust samples near the Dzhidinski ore processing mill, eastern Siberia, Russia. Cardiovascular Toxicology (2019); 19, 401–411.

Price DN*, Kunda NK*, Muttil P. Challenges associated with the pulmonary delivery of therapeutic dry powders for preclinical testing. Kona Powder and Particle Journal (2019); 36: 129-144.

Kunda NK*, Price DN*, Muttil P. Respiratory Tract Deposition and Distribution Pattern of Microparticles in Mice Using Different Pulmonary Delivery Techniques. Vaccines (Basel) (2018); 10:6(3). pii:E41

Rodrigues TC, Oliveira MLS, Soares-Schanoski A, Figueiredo DB, Stefanni R, Gonçalves VM, Ferreira DM, Kunda NK, Saleem IY, Miyaji EN. “Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed dry powder nanoparticles elicits protection against pneumococcal challenge.” PLoS One (2018); 13(1): e0191692.

Petkar KC, Chavan S, Kunda NK, Saleem I, Somavarapu S, Taylor K, Sawant KK. Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design. AAPS PharmSciTech (2018); 19, 1758–1772.

Zychowski KE, Kodali V, Harmon M, Tyler CR, Sanchez B, Ordonez Suarez Y, Herbert G, Wheeler A, Avasarala S, Cerrato JM, Kunda NK, Muttil P, Shuey C, Brearley A, Ali A, Lin Y, Shoeb M, Erdely A, Campen MJ. Respirable Uranyl-Vanadate Containing Particulate Matter Derived from a Legacy Uranium Mine Site Exhibits Potentiated Cardiopulmonary Toxicity. Toxicological Sciences (2018); 164(1):101-114.

Kunda NK, Hautmann J, Godoy, SE, Marshik P, Chand R, Krishna S, Muttil P. “A novel approach to study the pMDI plume using an infrared camera and to evaluate the aerodynamic properties after varying the time between actuations.” International Journal of Pharmaceutics (2017); 526 (1): 41-49.

Price DN, Lamoureux L, Kunda NK, Muttil P. In vivo pulmonary delivery and targeting of magnetically responsive dry powder nano-in-microparticles. Molecular Pharmaceutics (2017); 14(12): 4741–4750.

Kunda NK*, Wafula D*, Tram M, Wu TH, Muttil P. A Stable Live Bacterial Vaccine. European Journal of Pharmaceutics and Biopharmaceutics (2016); 103: 109-17.

Price DP*, Kunda NK*, McBride AA, Muttil P. "Vaccine Preparation: Past, Present, and Future." in Delivery Systems for Tuberculosis Prevention and Treatment edited by Anthony J Hickey, Amit Misra, and P Bernard Fourie. John Wiley & Sons. ISBN: 9781118943175 (2016).

Kunda NK, Alfagih IM, Miyaji EN, Figueiredo DB, Gonçalves VM, Ferreira DM, Dennison SR, Somavarapu S, Hutcheon GA, Saleem IY. Pulmonary Dry Powder Vaccine of Pneumococcal Antigen loaded Nanoparticles. International Journal of Pharmaceutics (2015); 495(2): 903-912.

Kunda NK, Alfagih IM, Dennison SR, Tawfeek HM, Somavarapu S, Hutcheon GA, Saleem IY. Bovine Serum Albumin Adsorbed PGA-Co-PDL Nanocarriers for Vaccine Delivery via Dry Powder Inhalation. Pharmaceutical Research (2015); 32(4): 1341-53.

Kunda NK, Alfagih IM, Dennison SR, Somavarapu S, Merchant Z, Hutcheon GA, Saleem IY. Dry Powder Pulmonary Delivery of Cationic PGA-Co-PDL Nanoparticles with Surface Adsorbed Model Protein. International Journal of Pharmaceutics (2015); 492(1-2): 213-222.

Alfagih IM, Kunda NK, Alanazi F, Somavarapu S, Hutcheon GA, Saleem IY. Pulmonary Delivery of Protein using Nanocomposite Microparticle Carriers. Journal of Pharmaceutical Sciences (2015); 104(12):4386-4398.

Merchant Z, Taylor KM, Stapleton P, Razak SA, Kunda NK, Alfagih IM, Saleem IY, Somavarapu S. Engineering Hydrophobically Modified Chitosan for Enhancing the Dispersion of Respirable Microparticles of Levofloxacin. European Journal of Pharmaceutics and Biopharmaceutics (2014); 88 (3): 816-29.

Kunda NK, Alfagih IM, Saleem IY, Hutcheon GA. "Polymer-Based Delivery Systems for the Pulmonary Delivery of Macromolecules." in Pulmonary Drug Delivery: Advances and Challenges edited by Professors Ali Nokhodchi and Gary Martin. John Wiley & Sons. ISBN: 9781118799543 (2015).

Kunda NK, Somavarapu S, Gordon SB, Hutcheon GA, Saleem IY. Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery. Pharmaceutical Research (2013); 30(2): 325-41.